Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition of anti-leukotriene agents to inhaled corticosteroids for chronic asthmaCysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cellsExpression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1RCysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association StudiesAn open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthmaG-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveChronic asthma.Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distributionLeukotriene receptor antagonists: efficacy and safety in children with asthma.Update in internal medicine.Pharmacology and safety of the leukotriene antagonists.Efficacy of anti-LT agents in the treatment of chronic asthma.New perspectives for asthma treatment: anti-leukotriene drugs.Anti-leukotrienes in asthma: yet to arrive.Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.State of the art: therapeutic controversies in severe acute asthma.Leukotriene receptor antagonist therapyZafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.Update on the role of leukotrienes in the pathogenesis of atopy: a comparative review.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.Zafirlukast for severe recurrent vulvovaginal candidiasis: an open label pilot study.Treatment of canine atopic dermatitis with zafirlukast, a leukotriene-receptor antagonist: a single-blinded, placebo-controlled studyThe G protein-coupled receptors: pharmacogenetics and disease.Overcoming gaps in the management of asthma in older patients: new insights.Cost effectiveness of leukotriene modifiers in adults with asthma.Tolerance and rebound with zafirlukast in patients with persistent asthmaTreatment heterogeneity in asthma: genetics of response to leukotriene modifiers.A cost-effectiveness analysis of first-line controller therapies for persistent asthma.Leukotriene pathway in sickle cell disease: a potential target for directed therapy.Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.Asthma management. The case for aiming at control rather than merely relief.Airway eosinophil migration into lymph nodes in mice depends on leukotriene C4.Breathing easier.Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors.Summary of clinical trials with zafirlukast
P2860
Q24197682-F7012705-4FDE-41E4-AA3E-8D57B3E458C9Q24200804-7C28FD9C-F617-4709-9F51-4AC8122624CDQ24202489-F38E1F3C-7957-40CB-9DD0-49017E999D13Q24247433-9A2797A3-478E-4BD1-9160-88013DF21794Q24247489-03D55562-A34B-4EFB-9B31-A1E7BCD22A69Q24632991-57E3C8E1-33AB-4FEE-A49C-A6AB53C3ADDBQ24673057-BF40FF5E-6B49-4EBD-AFF0-3FDC831B4BC0Q28067073-ADE41F74-B08C-4210-9BBF-5883F077F4F7Q28189893-959588E6-3A0A-4EBA-A977-230A981691ABQ28212087-0BA99C65-1944-4BAE-B64E-0BCB85DF41C2Q28362642-3048FBB5-E3D0-4A2C-804B-174F1364C54EQ28507320-0E74ED10-71AC-4160-B2FF-93E75E21C6C0Q31420368-3F843D16-982E-4C7B-9AE6-2BD887C71C80Q33588350-5E268679-1693-4ADF-99C1-265F38F10582Q33705502-6D6AD4E8-D5D6-4954-912F-63A63233A27BQ33705518-E08099BA-7B9D-4B8F-88F0-5ECB732E8CF9Q33729339-681E0782-CFD6-4420-8297-7EC3CA9363CFQ33930448-942814BE-A422-43B7-B47F-C48E035D3B5CQ33976334-62BA59AF-188C-4BC9-AE88-2621C2956147Q33978718-03F2E401-59C9-4A3B-A96B-19B14CD649A6Q33985196-AF4B4627-E3D9-4B96-8BF9-073B7BA237CBQ34086351-4A960AE9-26CC-4489-B797-F9296E7F5F6CQ34196648-C266B17D-EEBD-4BB7-9CDD-C4750D82084AQ34255709-DE10B4AB-73D0-4E1C-88BD-ADE566875171Q34424227-21C7A51A-DC2A-40BF-A933-11DAFE71FD98Q35531249-EEA9EB7D-19B9-4E26-B7E8-9B39CA3E246FQ36082876-F687FF24-E2E0-4E0C-8E89-016AC0D270C7Q36310854-0D02052C-15AE-4EC9-A2CD-EF11369CF0CAQ36346376-3F10D45F-CA67-40A4-9E77-9250490A95F2Q36561046-98EDA3BA-D9C7-41EF-9AEC-4A22002932A6Q36717710-3D46EE78-4E89-4CB2-9CD5-DD782FCC86EAQ36775615-D6E89420-61D7-40C2-9691-615A7E5A150CQ36870013-36201291-263A-49B7-95F4-49A2BCC70840Q37810108-ECD802D6-E265-4B26-B1BE-EFEE48EAADECQ39104480-1BC2C023-CAE0-4B2D-838C-911E1B6C0EEDQ39449843-2B5808B6-34C0-4D35-9B25-FE1A01DE53C0Q40440817-18DE8378-5C06-4AF8-A567-0B47B23B196FQ41674096-49D5EE00-5D21-4FDE-8813-2F62AD166C16Q42002168-0E114C6C-2C80-474D-95EC-579554B3EE85Q42541808-8CD00DF8-81FB-4220-8B6C-1BC25A5BE3EE
P2860
Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Effectiveness of the leukotrie ...... ind, placebo-controlled trial.
@en
Effectiveness of the leukotrie ...... ind, placebo-controlled trial.
@nl
type
label
Effectiveness of the leukotrie ...... ind, placebo-controlled trial.
@en
Effectiveness of the leukotrie ...... ind, placebo-controlled trial.
@nl
prefLabel
Effectiveness of the leukotrie ...... ind, placebo-controlled trial.
@en
Effectiveness of the leukotrie ...... ind, placebo-controlled trial.
@nl
P2093
P1476
Effectiveness of the leukotrie ...... lind, placebo-controlled trial
@en
P2093
S Wood-Dauphinee
P304
P356
10.7326/0003-4819-126-3-199702010-00001
P407
P577
1997-02-01T00:00:00Z